13F HOLDINGS REPORT
Column Group LLC
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0000950123-23-005442
Total Value
$276.6M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Revolution Medicines Inc | RVMDW | 4,577,840 | $99.2M | 35.85% |
| 2 | NGM Biopharmaceuticals Inc | 62921N105 | 18,136,735 | $74.0M | 26.76% |
| 3 | RAPT Therapeutics Inc | 75382E109 | 2,680,621 | $49.2M | 17.79% |
| 4 | Tenaya Therapeutics, Inc. | TNYA | 9,400,290 | $26.8M | 9.69% |
| 5 | ORIC Pharmaceuticals Inc. | ORIC | 3,568,181 | $20.3M | 7.35% |
| 6 | Surrozen, Inc. | SRZNW | 9,248,129 | $5.6M | 2.01% |
| 7 | eFFECTOR Therapeutics Inc | 28202V108 | 4,309,329 | $1.5M | 0.55% |